Barclays’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Buy
32,356
+16,912
+110% +$963K ﹤0.01% 2256
2025
Q4
$653K Sell
15,444
-1,235
-7% -$69.1K ﹤0.01% 3703
2025
Q3
$949K Buy
16,679
+7,670
+85% +$254K ﹤0.01% 3397
2025
Q2
$233K Sell
9,009
-6,776
-43% -$76.1K ﹤0.01% 4186
2025
Q1
$161K Sell
15,785
-5,936
-27% -$77.6K ﹤0.01% 4163
2024
Q4
$303K Sell
21,721
-2,165
-9% -$38.2K ﹤0.01% 4115
2024
Q3
$466K Buy
23,886
+11,706
+96% +$223K ﹤0.01% 3824
2024
Q2
$227K Sell
12,180
-26,018
-68% -$548K ﹤0.01% 3514
2024
Q1
$535K Buy
38,198
+338
+0.9% +$3.54K ﹤0.01% 3545
2023
Q4
$321K Buy
37,860
+22,537
+147% +$171K ﹤0.01% 4164
2023
Q3
$137K Buy
15,323
+11,501
+301% +$111K ﹤0.01% 3471
2023
Q2
$33K Sell
3,822
-6,362
-62% -$67.8K ﹤0.01% 4007
2023
Q1
$107K Sell
10,184
-743
-7% -$22.5K ﹤0.01% 4138
2022
Q4
$370K Buy
10,927
+1,297
+13% +$62.8K ﹤0.01% 3496
2022
Q3
$463K Sell
9,630
-7,406
-43% -$441K ﹤0.01% 2743
2022
Q2
$971K Buy
17,036
+4,238
+33% +$267K ﹤0.01% 2382
2022
Q1
$1.03M Buy
12,798
+7,574
+145% +$1.12M ﹤0.01% 2372
2021
Q4
$1.06M Sell
5,224
-4,097
-44% -$889K ﹤0.01% 2797
2021
Q3
$2.51M Sell
9,321
-4,637
-33% -$1.11M ﹤0.01% 2157
2021
Q2
$3.59M Buy
13,958
+12,790
+1,095% +$3.54M ﹤0.01% 1795
2021
Q1
$350K Sell
1,168
-1,249
-52% -$389K ﹤0.01% 3408
2020
Q4
$616K Sell
2,417
-11,357
-82% -$2.93M ﹤0.01% 3112
2020
Q3
$3.43M Sell
13,774
-2,793
-17% -$879K ﹤0.01% 1667
2020
Q2
$5.75M Sell
16,567
-6,731
-29% -$2.1M 0.01% 1277
2020
Q1
$6.24M Buy
23,298
+12,461
+115% +$3.85M 0.01% 1294
2019
Q4
$3.51M Sell
10,837
-22,229
-67% -$6.45M ﹤0.01% 2395
2019
Q3
$9.03M Buy
33,066
+16,365
+98% +$6M 0.01% 1367
2019
Q2
$8.91M Buy
16,701
+1,976
+13% +$991K 0.01% 1429
2019
Q1
$7.42M Buy
14,725
+281
+2% +$167K 0.01% 1410
2018
Q4
$7.12M Sell
14,444
-4,846
-25% -$2.93M 0.01% 1356
2018
Q3
$17.6M Sell
19,290
-7,610
-28% -$6.5M 0.03% 925
2018
Q2
$19.7M Buy
26,900
+7,978
+42% +$9.2M 0.04% 789
2018
Q1
$30.2M Sell
18,922
-7,065
-27% -$9.1M 0.04% 646
2017
Q4
$23.3M Buy
25,987
+10,525
+68% +$6.23M 0.04% 728
2017
Q3
$5.57M Buy
15,462
+3,167
+26% +$991K 0.01% 1455
2017
Q2
$3.6M Sell
12,295
-9,192
-43% -$2.66M 0.01% 1726
2017
Q1
$7.56M Buy
21,487
+15,004
+231% +$3.37M 0.02% 1057
2016
Q4
$1.19M Buy
6,483
+6,158
+1,895% +$1.25M ﹤0.01% 2580
2016
Q3
$83K Sell
325
-430
-57% -$111K ﹤0.01% 4639
2016
Q2
$160K Buy
755
+521
+223% +$116K ﹤0.01% 4087
2016
Q1
$45K Sell
234
-2,347
-91% -$451K ﹤0.01% 4835
2015
Q4
$620K Sell
2,581
-226
-8% -$46.5K ﹤0.01% 3034
2015
Q3
$421K Buy
2,807
+348
+14% +$61.6K ﹤0.01% 3506
2015
Q2
$443K Sell
2,459
-2,114
-46% -$364K ﹤0.01% 3569
2015
Q1
$754K Sell
4,573
-1,923
-30% -$395K ﹤0.01% 3229
2014
Q4
$1.46M Buy
6,496
+4,744
+271% +$1.01M ﹤0.01% 2815
2014
Q3
$316K Sell
1,752
-27,440
-94% -$5.25M ﹤0.01% 4357
2014
Q2
$5.25M Buy
29,192
+18,793
+181% +$3.32M 0.01% 1695
2014
Q1
$1.87M Buy
10,399
+8,818
+558% +$1.75M ﹤0.01% 2619
2013
Q4
$260K Sell
1,581
-32,384
-95% -$5.22M ﹤0.01% 4754
2013
Q3
$5.09M Buy
33,965
+18,072
+114% +$3.34M 0.01% 1665
2013
Q2
$2.75M Buy
+15,893
New +$2.44M 0.01% 2186

Other funds holding NKTR